|
|
|||
|
||||
OverviewThe Maudsley Prescribing Guidelines in Psychiatry The new edition of the world-renowned reference guide on the use of medications for patients presenting with mental health problems The Maudsley Prescribing Guidelines in Psychiatry is the essential evidence-based handbook on the safe and effective prescribing of psychotropic agents. Covering both common and complex prescribing situations encountered in day-to-day clinical practice, this comprehensive resource provides expert guidance on drug choice, minimum and maximum doses, adverse effects, switching medications, prescribing for special patient groups, and more. Each clear and concise chapter includes an up-to-date reference list providing easy access to the evidence on which the guidance is based. The fourteenth edition has been fully updated to incorporate the latest available research, the most recent psychotropic drug introductions, and all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand, and Japan. Several new sections cover topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions by an experienced team of psychiatrists and specialist pharmacists, the new edition of The Maudsley Prescribing Guidelines in Psychiatry: Provides succinct coverage of drug treatment of psychiatric conditions and formulating prescribing policy in mental health Covers a wide range of psychiatric conditions including schizophrenia, bipolar disorder, depression and anxiety, borderline personality, eating disorders, and many others Provides advice on prescribing for children and adolescents, older people, pregnant women, and other special patient groups Offers new sections on genetic prescribing, long-acting injectable formulations, ketamine administration and uses, and dopamine super-sensitivity Includes referenced information on off-label prescribing, potential interactions with other substances such as alcohol, tobacco, and caffeine, and treating patients with comorbid physical conditions Whether in the doctor's office, in the clinic, or on the ward, The Maudsley Prescribing Guidelines in Psychiatry, Fourteenth Edition is a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses, and other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy, and nursing. Full Product DetailsAuthor: David M. Taylor (Maudsley Hospital) , Thomas R. E. Barnes (Charing Cross & Westminster Medical School, London, UK) , Allan H. Young (King's College, London, UK)Publisher: John Wiley and Sons Ltd Imprint: Wiley-Blackwell Edition: 14th edition Dimensions: Width: 16.80cm , Height: 3.80cm , Length: 24.10cm Weight: 1.361kg ISBN: 9781119772224ISBN 10: 1119772222 Pages: 976 Publication Date: 17 June 2021 Audience: Professional and scholarly , Professional & Vocational Replaced By: 9781394238767 Format: Paperback Publisher's Status: Active Availability: In stock We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsPreface xi Acknowledgments xii Notes on using The Maudsley Prescribing Guidelines in Psychiatry xiii List of abbreviations xv Part 1 Drug treatment of major psychiatric conditions 1 Chapter 1 Schizophrenia and related psychoses 3 ANTIPSYCHOTIC DRUGS 3 ANTIPSYCHOTIC ADVERSE EFFECTS 109 REFRACTORY SCHIZOPHRENIA AND CLOZAPINE 190 CLOZAPINE ADVERSE EFFECTS 212 Chapter 2 Bipolar disorder 247 Chapter 3 Depression and anxiety disorders 305 Chapter 4 Addictions and substance misuse 451 Part 2 Drug treatment of special patient groups 537 Chapter 5 Children and adolescents 539 Chapter 6 Prescribing in older people 601 Chapter 7 Pregnancy and breastfeeding 679 Chapter 8 Hepatic and renal impairment 723 Part 3 Prescribing in specialist conditions 755 Chapter 9 Drug treatment of other psychiatric conditions 757 Chapter 10 Drug treatment of psychiatric symptoms occurring in the context of other disorders 777 Part 4 Other aspects of psychotropic drug use 831 Chapter 11 Pharmacokinetics 833 Chapter 12 Other substances 865 Chapter 13 Psychotropic drugs in special conditions 875 Chapter 14 Miscellany 897 Index 943ReviewsAuthor InformationDavid M. Taylor, BSc, MSc, PhD, FFRPS, FRPharmS, FRCPsych (Hon) is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at King's College, London. Thomas R. E. Barnes, MBBS, MD, FRCPsych, DSc, is Emeritus Professor of Clinical Psychiatry at Imperial College London and joint-head of the Prescribing Observatory for Mental Health at the Royal College of Psychiatrists' Centre for Quality Improvement. Allan H. Young, MB, ChB, MPhil, PhD, FRCPC, FRCPsych, is Chair of Mood Disorders and is Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry at King's College London, UK. Tab Content 6Author Website:Countries AvailableAll regions |